功能性基因型分类可区分隐性营养不良型大疱性表皮松解症的疾病严重程度
本研究纳入236例北美隐性营养不良型大疱性表皮松解症(RDEB)患者,依据已发表报道或计算机预测评估COL7A1变异对Ⅶ型胶原(C7)功能的影响,将基因型分为低、中、高影响三组。结果显示功能影响严重程度与胃造瘘管置入史、食管扩张、手部手术、贫血、肾脏疾病、慢性伤口、弥漫性皮肤受累及鳞状细胞癌史显著相关。高影响组死亡风险为中影响组的3.5倍(95%CI 1.24-8.50;P=0.02),提示功能性基因型分类可用于风险分层。
要点
- 依据COL7A1变异对C7功能影响分为低、中、高三类,与多项临床严重结局相关
- 高影响组死亡风险为中影响组的3.5倍(95%CI 1.24-8.50;P=0.02)
- 功能性基因型分类可作为RDEB患者风险分层的可行方法
核心结论
- 功能性基因型分类可依据预测的C7功能对RDEB患者进行风险分层,高影响组临床结局更差、死亡风险更高。
研究设计与样本
- 研究纳入236例北美RDEB患者,依据已发表报道或计算机预测评估COL7A1变异对C7功能的影响,并据此分为低、中、高影响三组。
主要发现
- 功能影响严重程度与胃造瘘管置入史、食管扩张、手部手术、贫血、肾脏疾病、慢性伤口、弥漫性皮肤受累及鳞状细胞癌史显著相关。
- 高影响组死亡风险为中影响组的3.5倍(95%CI 1.24-8.50;P=0.02)。
- 高影响组患者的临床结局更差。
关键数值与推荐
- 低影响组:剪接B/错义、错义/错义。
- 中影响组:提前终止密码子(PTC)/剪接B、剪接A/剪接B、PTC/错义、剪接A/错义、剪接B/剪接B。
- 高影响组:PTC/PTC、PTC/剪接A、剪接A/剪接A。
- 剪接A变异预测导致下游PTC,剪接B变异导致框内外显子跳跃、危害较小。
临床怎么用
- 临床可依据COL7A1变异对C7功能的影响进行基因型分类,用于RDEB患者的风险分层与严重程度预判。
局限性
- 基因型功能影响依据已发表报道或计算机预测评估,而非全部经实验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic disorder caused by pathogenic variants in COL7A1. OBJECTIVES: To determine the association between different COL7A1 variants and clinical disease severity in 236 North American patients with RDEB. METHODS: Published reports or in silico predictions were used to assess the impact of pathogenic variants in COL7A1 on type VII collagen (C7) protein function. Three impact categories were postulated: genotypes that would be likely to cause a low impact on C7 function (splice B/missense, missense/missense); a medium impact [premature termination codon (PTC)/splice B, splice A/splice B, PTC/missense, splice A/missense, splice B/splice B]; and a high impact (PTC/PTC, PTC/splice A, splice A/splice A). Splice A variants are predicted to cause downstream PTCs, while splice B variants cause in-frame exon skipping and are therefore less deleterious. RESULTS: The severity of functional impact was significantly associated with a history of gastrostomy tube placement, oesophageal dilation, hand surgery, anaemia, renal disease, chronic wounds, diffuse skin involvement and a history of squamous cell carcinoma. The odds of death were 3.5 time higher in the high-impact vs. medium-impact group (95% confidence interval 1.24-8.50; P = 0.02). Patients in the high-impact group had worse clinical outcomes. CONCLUSIONS: Functional genotype categories are a feasible approach to risk-stratify patients based on predicted C7 function. Epidermolysis bullosa (‘EB’ for short) is a group of rare inherited conditions that cause the skin to blister easily. A type of EB known as ‘recessive dystrophic EB’ (or ‘RDEB’ for short) is caused by changes in a gene called ‘COL7A1’. Much of the skin is covered in blisters at birth or shortly afterwards. There is also extensive blistering on the inside of the body. The exact number of people with EB is unclear. However, estimates suggest that 25,000 to 50,000 people in the USA have EB. Less than five percent of all cases of EB are classified as RDEB. In this study, we looked at how different changes in the COL7A1 gene affect how severe the disease is in 236 patients with RDEB in North America. We used information from other studies or computer predictions to see how these genetic changes affect a protein called ‘type VII collagen’ (‘C7’ for short). We divided these genetic changes into three groups based on how much they affect C7: low-impact, medium-impact and high-impact. Patients in the high-impact group were more likely to have more severe complications like needing a tube for feeding, surgery on the hands or other health issues. They also had a higher chance of dying and a history of a serious type of skin cancer called squamous cell carcinoma. By understanding how these genetic changes affect proteins and by categorizing patients into different groups, doctors can better understand and predict how severe RDEB might be for each patient.
引用
- Pathmarajah P, Eid E, Nazaroff J, et al. Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. Br J Dermatol. 2025. PMID: 39790012. doi:10.1093/bjd/ljaf015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。